KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Novartis Ag (NVS) Income from Continuing Operations (2016 - 2025)

Novartis Ag's Income from Continuing Operations history spans 14 years, with the latest figure at 4531000000.0 for Q2 2025.

  • On a quarterly basis, Income from Continuing Operations rose 17.96% to 4531000000.0 in Q2 2025 year-over-year; TTM through Jun 2025 was 20536000000.0, a 36.33% increase, with the full-year FY2025 number at 13967000000.0, up 16.99% from a year prior.
  • Income from Continuing Operations hit 4531000000.0 in Q2 2025 for Novartis Ag, down from 6970000000.0 in the prior quarter.
  • Over the last five years, Income from Continuing Operations for NVS hit a ceiling of 6970000000.0 in Q4 2024 and a floor of 514000000.0 in Q1 2021.
  • Historically, Income from Continuing Operations has averaged 3617071428.57 across 5 years, with a median of 4621000000.0 in 2022.
  • Biggest five-year swings in Income from Continuing Operations: skyrocketed 164.95% in 2021 and later crashed 30.28% in 2024.
  • Tracing NVS's Income from Continuing Operations over 5 years: stood at 5956000000.0 in 2021, then fell by 20.9% to 4711000000.0 in 2022, then grew by 10.25% to 5194000000.0 in 2023, then soared by 34.19% to 6970000000.0 in 2024, then tumbled by 34.99% to 4531000000.0 in 2025.
  • Business Quant data shows Income from Continuing Operations for NVS at 4531000000.0 in Q2 2025, 6970000000.0 in Q4 2024, and 3841000000.0 in Q2 2024.